Literature DB >> 10889028

Recognition of alpha-amino acids bearing various C=NOH functions by nitric oxide synthase and arginase involves very different structural determinants.

C Moali1, M Brollo, J Custot, M A Sari, J L Boucher, D J Stuehr, D Mansuy.   

Abstract

Several alpha-amino acids bearing a C=NOH function separated from the Calpha carbon by two to five atoms have been synthesized and tested as substrates or inhibitors of recombinant nitric oxide synthases (NOS) I and II and as inhibitors of rat liver arginase (RLA). These include four N-hydroxyguanidines, N(omega)-hydroxy-L-arginine (NOHA) and its analogues homo-NOHA, nor-NOHA, and dinor-NOHA, two amidoximes bearing the -NH-C(CH(3))=NOH group, and two amidoximes bearing the -CH(2)-C(NH(2))=NOH group. Their behavior toward NOS and RLA was compared to that of the corresponding compounds bearing a C=NH function instead of the C=NOH function. The results obtained clearly show that efficient recognition of these alpha-amino acids by NOS and RLA involves very different structural determinants. NOS favors molecules bearing a -NH-C(R)=NH motif separated from Calpha by three or four CH(2) groups, such as arginine itself, with the necessary presence of delta-NH and omega-NH groups and a more variable R substituent. The corresponding molecules with a C=NOH function exhibit a much lower affinity for NOS. On the contrary, RLA best recognizes molecules bearing a C=NOH function separated from Calpha by three or four atoms, the highest affinity being observed in the case of three atoms. The presence of two omega-nitrogen atoms is important for efficient recognition, as in the two best RLA inhibitors, N(omega)-hydroxynorarginine and N(omega)-hydroxynorindospicine, which exhibit IC(50) values at the micromolar level. However, contrary to what was observed in the case of NOS, the presence of a delta-NH group is not important. These different structural requirements of NOS and RLA may be directly linked to the position of crucial residues that have been identified from crystallographic data in the active sites of both enzymes. Thus, binding of arginine analogues to NOS particularly relies on strong interactions of their delta-NH and omega-NH(2) groups with glutamate 371 (of NOS II), whereas binding of C=NOH molecules to RLA is mainly based on interactions of their terminal OH group with the binuclear Mn(II).Mn(II) cluster of the enzyme and on possible additional bonds between their omega-NH(2) group with histidine 141, glutamate 277, and one Mn(II) ion. The different modes of interaction displayed by both enzymes depend on their different catalytic functions and give interesting opportunities to design useful molecules to selectively regulate NOS and arginase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889028     DOI: 10.1021/bi992992v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  From inflammation to wound healing: using a simple model to understand the functional versatility of murine macrophages.

Authors:  Lauren M Childs; Michael Paskow; Sidney M Morris; Matthias Hesse; Steven Strogatz
Journal:  Bull Math Biol       Date:  2011-02-23       Impact factor: 1.758

3.  Inhibition of human arginase I by substrate and product analogues.

Authors:  Luigi Di Costanzo; Monica Ilies; Katherine J Thorn; David W Christianson
Journal:  Arch Biochem Biophys       Date:  2010-02-12       Impact factor: 4.013

Review 4.  Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.

Authors:  Jihoon Kim; Susan N Thomas
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

5.  Oxygen Binding by Co(II) Complexes with Oxime-Containing Schiff Bases in Solution.

Authors:  Marek Pająk; Magdalena Woźniczka; Marta E Lichawska; Bartłomiej Czerwiński; Jakub Włodarczyk; Jakub Fichna
Journal:  Int J Mol Sci       Date:  2022-05-14       Impact factor: 6.208

6.  Binding of the unreactive substrate analog L-2-amino-3-guanidinopropionic acid (dinor-L-arginine) to human arginase I.

Authors:  Edward L D'Antonio; David W Christianson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-27

7.  Schistosoma mansoni arginase shares functional similarities with human orthologs but depends upon disulphide bridges for enzymatic activity.

Authors:  Jennifer M Fitzpatrick; Jose M Fuentes; Iain W Chalmers; Thomas A Wynn; Manuel Modolell; Karl F Hoffmann; Matthias Hesse
Journal:  Int J Parasitol       Date:  2008-08-06       Impact factor: 3.981

8.  The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages.

Authors:  V Iniesta; L C Gómez-Nieto; I Corraliza
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

9.  Phenyl 2-pyridyl ketoxime induces cellular senescence-like alterations via nitric oxide production in human diploid fibroblasts.

Authors:  Kyeong Eun Yang; Hyun-Jin Jang; In-Hu Hwang; Young-Ho Chung; Jong-Soon Choi; Tae-Hoon Lee; Yun-Jo Chung; Min-Seung Lee; Mi Young Lee; Eui-Ju Yeo; Ik-Soon Jang
Journal:  Aging Cell       Date:  2015-12-22       Impact factor: 9.304

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.